Valsartan reduced diabetes but not CV events in patients with impaired glucose tolerance and CV risk factors
- Nateglinide did not reduce diabetes or CV events in patients with impaired glucose tolerance and CV risk factors. Farkouh, Michael // ACP Journal Club;6/15/2010, Vol. 152 Issue 6, p9
The article offers information on the clinical trial conducted on the use of the drug nateglinide in older adult patients with impaired glucose tolerance to reduce diabetes and cardiovascular disease (CV) risk factors. The trial studied 9518 patients of 50 years of age suffering from glucose...
- Cardiovascular Risk Among Older Hispanic Women. Etnyre, Annette; Rauschhuber, Maureen; Gilliland, Irene; Cook, Jennifer; Mahon, Marveen; Allwein, David; Sethness, Renee; Lowry, Jolynn; Jones, Mary Elaine // AAOHN Journal;Mar2006, Vol. 54 Issue 3, p120
This study used a descriptive correlational design to describe the relationship between cardiovascular risk and anxiety, spirituality, acculturation, and the objective indices of cardiac risk among a sample of 21 adult Hispanic women. Objective indices of risk included weight, blood pressure,...
- The effect of different cardiovascular risk presentation formats of intentions, understanding and emotional affect: a randomised controlled trial using a web-based risk formatter (protocol). Waldron, Cherry-Ann; Gallacher, John; van der Weijden, Trudy; Newcombe, Robert; Elwyn, Glyn // BMC Medical Informatics & Decision Making;2010, Vol. 10 Issue 1, p41
Background: The future risk of heart disease can be predicted with increasing precision. However, more research is needed into how this risk is conveyed and presented. The aim of this study is to compare the effects of presenting cardiovascular risk in different formats on individuals' intention...
- Pravastatin lowered coronary disease risk in elderly persons with or at risk for vascular disease. Havranek, Edward // ACP Journal Club;Jul/Aug2003, Vol. 139 Issue 1, p9
Presents an analysis of the effectiveness and safety of pravastatin in coronary disease risk in elderly persons with or at risk for vascular disease. Main outcome measures; Results; Factor which might have lessened the effect of statin therapy on stroke.
- Valsartan is more effective than placebo in reducing the incidence of diabetes in people with impaired glucose tolerance and cardiovascular disease or risk factors but has no effect on cardiovascular outcomes. Lacourcière, Yves; Poirier, Luc // Evidence Based Medicine;Aug2011, Vol. 16 Issue 4, p122
The article presents a commentary on the study "Effect of valsartan on the incidence of diabetes and cardiovascular events," published in a 2010 issue of the "New England Journal of Medicine." It points out the possibility that the study's findings were influenced by some methodological flaws....
- Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention: study protocol for a randomized controlled trial. Shih, Sophy T. F.; Davis-Lameloise, Nathalie; Janus, Edward D.; Wildey, Carol; Versace, Vincent L.; Hagger, Virginia; Asproloupos, Dino; O¿Reilly, Sharleen; Phillips, Paddy A.; Ackland, Michael; Skinner, Timothy; Oats, Jeremy; Carter, Rob; Best, James D.; Dunbar, James A. // Trials;2013, Vol. 14 Issue 1, p2
Background Gestational diabetes mellitus (GDM) is defined as glucose intolerance with its onset or first recognition during pregnancy. Post-GDM women have a life-time risk exceeding 70% of developing type 2 diabetes mellitus (T2DM). Lifestyle modifications reduce the incidence of T2DM by up to...
- Metabolic and Cardiovascular Complications in HIV-Infected Patients: Epidemiology, Pathogenesis, and Clinical Implications. // Journal of Infectious Diseases;Jun2012 Supplement 3, Vol. 205 Issue suppl_3, pNP
In this article, the topic "Metabolic and Cardiovascular Complications in HIV-Infected Patients: Epidemiology, Pathogenesis, and Clinical Implications," is presented.
- BNP predicts risk of heart failure in older people. // Pulse;2/10/2010, Vol. 70 Issue 4, p9
The article reports that the natriuretic peptide of N-terminal pro-B type can assist patients in detecting risk of heart failure and cardiovascular death in older people in Great Britain.
- Promoting and Prescribing Exercise for the Elderly. // American Family Physician;Feb2002, Vol. 65 Issue 3, p419
Regular exercise provides a myriad of health benefits in older adults, including improvements in blood pressure, diabetes, lipid profile, osteoarthritis, osteoporosis, and neurocognitive function. Regular physical activity is also associated with decreased mortality and age-related morbidity in...